Navigation Links
New research seeks to improve survival for myeloma and lymphoma patients

Researchers at the University of York are launching a major study of lymphoma and myeloma aimed at promoting earlier diagnosis and improving survival for patients with these cancers, which are among the most common in the UK.

The project, which is funded by Cancer Research UK as part of the National Awareness and Early Diagnosis Initiative (NAEDI), will develop an evidence base that could be used to reduce time-to-diagnosis in patients with these types of cancers.

Led by Dr Debra Howell of the Epidemiology and Genetics Unit in the University's Department of Health Sciences, the 300,000 study is prompted by data indicating that survival for many cancers is poorer in the UK than Europe.

Dr Howell says: "The UK Improving Outcomes Guidance for cancer considers that the most important reason for this is likely to be late stage diagnosis; earlier diagnosis may increase the scope for successful treatment and could save thousands of lives.

"There are nearly 15,000 new diagnoses annually of lymphoma (Hodgkin and non-Hodgkin) and myeloma in the UK, and early diagnosis is complicated by the complex nature of these diseases. The symptoms of lymphoma and myeloma can be strikingly similar to those of more common, benign conditions and this poses exacting challenges for both patients and GPs when identifying symptoms that may indicate malignancy. This situation often leads to delayed help-seeking and prevents early hospital referral."

Patients said:

"The doctors were concerned about these swollen glands in my neck which I'd had for a couple of months. I never thought anything about it because they didn't hurt."

"I just thought it was a swollen gland. It could have been an infection of the throat."

"I got the lump taken away and the doctor said I'm sorry to have to say that it's lymphoma. But prior to that I hadn't felt poorly. Nothing. I've had no symptoms. I've not been poorly at all really."

Despite UK Referral Guidance, data from the National Cancer Data Repository (2007) reported that patients with haematological malignancies, including lymphoma and myeloma, were generally more often diagnosed after emergency presentation and less often referred via the Government recommended two-week wait compared to those with other cancers.

The new study will include a cohort of around 1000 patients newly diagnosed with lymphoma or myeloma during 2012.

Its specific objectives are to:

  • interview patients to explore their symptoms before diagnosis, how they reacted to these and from whom they sought help
  • use primary care (GP) and hospital records to examine events between patients seeking help and diagnosis, such as GP appointments and hospital referrals

The evidence generated will inform UK clinical guidance and could be used to develop tools such as computer-based decision programmes to help GPs to identify patients with these cancers. This could help to promote appropriate investigation and referral, reduce time-to-diagnosis and improve survival outcomes. Educational resources will also be produced to encourage people with possible symptoms to seek help sooner.

The study is based on the infrastructure of the Haematological Malignancy Research Network (HMRN), which was established in 2004. HMRN is a specialist population-based registry, funded by Leukaemia and Lymphoma Research (LLR), which includes all patients newly diagnosed with a haematological malignancy within the Yorkshire and Humber and the Yorkshire Coast Cancer Network areas more than 2,000 new diagnoses from a population of 3.6 million each year.

Dr Howell adds: "As the HMRN area is representative of the UK as a whole in terms of both demography and clinical practice, the results could inform practice around the UK."

Contact: David Garner
University of York

Related medicine news :

1. Adolescent sexual behavior tied to motion picture sexual content exposure, says MU researcher
2. John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
3. Mount Sinai researchers discover new target for vaccine development in abundant immune cells
4. Researchers study vaccine as potential weapon against aggressive brain tumors
5. Researchers developing bioadhesive gel to protect women from HIV and HSV infections
6. Researchers find driver of breast cancer stem cell metastasis
7. Researchers unfold the mechanisms underlying blood disorders
8. Research shows potential of microneedles to target therapeutics to the back of the eye
9. New findings by GW researcher break tanning misconceptions: There is no such thing as a safe tan
10. Tel Aviv University research links childhood obesity to cancer risk
11. New lipid screening guidelines for children overly aggressive, UCSF researchers say
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... Dental professionals who ... Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) ... in Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. ...
(Date:11/25/2015)... IL (PRWEB) , ... November 25, 2015 , ... The ... announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex ... Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... a double board certified facial plastic surgeon specializing in both surgical and non-surgical ... of The Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study ... (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product and ... care units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, ...
(Date:11/25/2015)... Missouri (PRWEB) , ... November 25, 2015 , ... ... HEAL, will provide scholarships for people struggling with eating disorders as a result ... from the second annual event, held at Fox Run Golf Club in Eureka, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Advanced Wound Care Market by Type (Dressings, Therapy ... User (In-Patient Facility, Out-Patient Facility), and Geography - Global ... --> --> The ... definition and forecast of the global advanced wound care ...
Breaking Medicine Technology: